Susie Tappouni
312-949-3232
susie.tappouni@asco.org
CHICAGO - In addition to the abstracts featured in the official 2011 ASCO Annual Meeting Press Program, nine noteworthy studies on the prevention, screening, evaluation and management of several types of cancers were highlighted at the meeting. The 2011 ASCO Annual Meeting is being held June 3-7 at McCormick Place in Chicago.
Abstract 82085: Phase III randomized, double-blind, placebo-controlled trial of soy protein and venlafaxine for treatment of hot flashes in men with prostate cancer.
Lead Author: Mara Vitolins, MD
Poster Discussion Session
A13
Sunday, June 5
8:00 AM - 12:00 PM
Abstract 81907: Axitinib versus sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC): Results of phase III AXIS trial.
Lead Author: Brian Rini, MD
Oral Abstract Session
Monday, June 6
8:00 AM - 8:15 AM
Abstract 77126: Prospective and observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.
Lead Author: Michael Fisch, MD
Oral Abstract Session
Monday, June 6
11:00 AM - 11:15 AM
Abstract 82339: Cabozantinib (XL184) in metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized discontinuation trial.
Lead Author: Maha Hussain, MD
Oral Abstract Session
Monday, June 6
1:15 - 1:30 AM
Abstract 77834: Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer?
Lead Author: Susan M. Domcheck, MD
Oral Abstract Session
Monday, June 6
3:15 PM - 3:30 PM
Abstract 83283: PALETTE: A randomized, double-blind, phase III trial of pazopanib versus placebo in patients (pts) with soft-tissue sarcoma (STS) whose disease has progressed during or following prior chemotherapy-An EORTC STBSG Global Network Study (EORTC 62072).Lead Author: W. T. Van der Graaf, MD
Oral Abstract Session
Monday, June 6
3:30 PM - 3:45 PM
Abstract 83975: Metformin and breast cancer incidence in postmenopausal diabetic women in the Women's Health Initiative (WHI).
Lead Author: Rowan Chlebowski, MD
Oral Abstract Session
Monday, June 6
4:00 PM - 4:15 PM
Abstract 77463: Adjuvant capecitabine and oxaliplatin for gastric cancer: Results of the phase III CLASSIC trial.
Lead Author: Yung-Jue Bang, MD
Oral Abstract Session
Tuesday, June 7
10:15 AM - 10:30 AM
Abstract 78733: Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.
Lead Author: John P. Neoptolemos, MD
Oral Abstract Session
Tuesday, June 7
11:45 AM - 12:00 PM
Relevant Links on ASCO's patient website, www.Cancer.Net.
- Guide to Prostate Cancer
- Guide to Breast Cancer
- Guide to Bile Duct Cancer
- Guide to Stomach Cancer
- Guide to Kidney Cancer
- Guide to Colorectal Cancer
- Guide to Sarcoma
- Chronic Conditions: When Cancer is Not Your Only Health Concern
- The Genetics of Breast Cancer
- Chemoprevention
- Understanding Chemotherapy
- Understanding Targeted Treatments
- Managing and Treating Cancer Pain
Click here to download the press release.
ATTRIBUTION TO THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING IS REQUESTED IN ALL NEWS COVERAGE.
The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. Patient-oriented cancer information is available at www.Cancer.Net.
